RhumbLine Advisers’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $97.6M | Sell |
250,277
-10,534
| -4% | -$4.45M | 0.07% | 225 |
|
|
2026
Q1 | $123M | Sell |
260,811
-18,713
| -7% | -$9.42M | 0.11% | 165 |
|
|
2025
Q4 | $130M | Sell |
279,524
-19,386
| -6% | -$9M | 0.11% | 152 |
|
|
2025
Q3 | $127M | Sell |
298,910
-16,320
| -5% | -$6.33M | 0.1% | 160 |
|
|
2025
Q2 | $121M | Sell |
315,230
-11,996
| -4% | -$4.32M | 0.1% | 164 |
|
|
2025
Q1 | $113M | Buy |
327,226
+13,142
| +4% | +$4.23M | 0.11% | 160 |
|
|
2024
Q4 | $94.3M | Sell |
314,084
-9,565
| -3% | -$3.34M | 0.08% | 190 |
|
|
2024
Q3 | $132M | Sell |
323,649
-431
| -0.1% | -$158K | 0.12% | 142 |
|
|
2024
Q2 | $104M | Sell |
324,080
-10,827
| -3% | -$3.52M | 0.1% | 168 |
|
|
2024
Q1 | $112M | Sell |
334,907
-24,849
| -7% | -$7.59M | 0.11% | 163 |
|
|
2023
Q4 | $97.4M | Sell |
359,756
-12,942
| -3% | -$3.2M | 0.1% | 175 |
|
|
2023
Q3 | $91.7M | Sell |
372,698
-5,168
| -1% | -$1.41M | 0.11% | 161 |
|
|
2023
Q2 | $115M | Sell |
377,866
-1,591
| -0.4% | -$442K | 0.13% | 134 |
|
|
2023
Q1 | $100M | Sell |
379,457
-3,162
| -0.8% | -$803K | 0.12% | 149 |
|
|
2022
Q4 | $91.8M | Buy |
382,619
+8,099
| +2% | +$1.81M | 0.12% | 156 |
|
|
2022
Q3 | $68.8M | Buy |
374,520
+30,414
| +9% | +$6.06M | 0.1% | 180 |
|
|
2022
Q2 | $57.8M | Sell |
344,106
-97
| -0% | -$20.8K | 0.08% | 214 |
|
|
2022
Q1 | $86.3M | Buy |
344,203
+4,987
| +1% | +$1.25M | 0.11% | 159 |
|
|
2021
Q4 | $87.2M | Buy |
339,216
+1,374
| +0.4% | +$336K | 0.11% | 162 |
|
|
2021
Q3 | $82M | Sell |
337,842
-21,033
| -6% | -$5.14M | 0.11% | 156 |
|
|
2021
Q2 | $74.2M | Sell |
358,875
-34,380
| -9% | -$7.01M | 0.1% | 175 |
|
|
2021
Q1 | $74.1M | Sell |
393,255
-33,739
| -8% | -$5.95M | 0.1% | 170 |
|
|
2020
Q4 | $70.2M | Sell |
426,994
-47,683
| -10% | -$6.97M | 0.1% | 174 |
|
|
2020
Q3 | $59.2M | Sell |
474,677
-9,650
| -2% | -$1.19M | 0.09% | 186 |
|
|
2020
Q2 | $47M | Buy |
484,327
+13,795
| +3% | +$1.43M | 0.08% | 220 |
|
|
2020
Q1 | $42.3M | Buy |
470,532
+27,080
| +6% | +$3.51M | 0.09% | 203 |
|
|
2019
Q4 | $65.5M | Sell |
443,452
-11,659
| -3% | -$1.57M | 0.11% | 176 |
|
|
2019
Q3 | $54.8M | Buy |
455,111
+5,477
| +1% | +$708K | 0.1% | 198 |
|
|
2019
Q2 | $60.8M | Buy |
449,634
+25,094
| +6% | +$3.17M | 0.11% | 175 |
|
|
2019
Q1 | $55.4M | Buy |
424,540
+7,441
| +2% | +$999K | 0.11% | 179 |
|
|
2018
Q4 | $51.9M | Buy |
417,099
+6,676
| +2% | +$896K | 0.11% | 169 |
|
|
2018
Q3 | $57.1M | Sell |
410,423
-12,170
| -3% | -$1.52M | 0.11% | 185 |
|
|
2018
Q2 | $43.4M | Sell |
422,593
-10,587
| -2% | -$1.07M | 0.09% | 218 |
|
|
2018
Q1 | $42M | Sell |
433,180
-8,385
| -2% | -$814K | 0.09% | 229 |
|
|
2017
Q4 | $38.8M | Buy |
441,565
+9,754
| +2% | +$784K | 0.08% | 257 |
|
|
2017
Q3 | $34.4M | Sell |
431,811
-3,382
| -0.8% | -$272K | 0.07% | 271 |
|
|
2017
Q2 | $37.9M | Sell |
435,193
-3,633
| -0.8% | -$307K | 0.09% | 244 |
|
|
2017
Q1 | $39.1M | Buy |
438,826
+13,914
| +3% | +$1.16M | 0.09% | 231 |
|
|
2016
Q4 | $31.5M | Buy |
424,912
+23,355
| +6% | +$1.75M | 0.08% | 263 |
|
|
2016
Q3 | $30.4M | Buy |
401,557
+13,321
| +3% | +$1.02M | 0.08% | 245 |
|
|
2016
Q2 | $29.9M | Buy |
388,236
+10,636
| +3% | +$840K | 0.09% | 233 |
|
|
2016
Q1 | $29.5M | Buy |
377,600
+21,571
| +6% | +$1.51M | 0.09% | 224 |
|
|
2015
Q4 | $24.1M | Sell |
356,029
-3,821
| -1% | -$267K | 0.08% | 253 |
|
|
2015
Q3 | $27.8M | Buy |
359,850
+22,835
| +7% | +$2.02M | 0.09% | 216 |
|
|
2015
Q2 | $30.6M | Buy |
337,015
+4,761
| +1% | +$381K | 0.1% | 214 |
|
|
2015
Q1 | $25M | Buy |
332,254
+127,879
| +63% | +$9.18M | 0.07% | 254 |
|
|
2014
Q4 | $15M | Buy |
204,375
+11,980
| +6% | +$842K | 0.04% | 377 |
|
|
2014
Q3 | $13.6M | Sell |
192,395
-428
| -0.2% | -$28.3K | 0.04% | 391 |
|
|
2014
Q2 | $10.9M | Buy |
192,823
+24,415
| +14% | +$1.29M | 0.03% | 465 |
|
|
2014
Q1 | $8.84M | Sell |
168,408
-6,075
| -3% | -$302K | 0.03% | 545 |
|
|
2013
Q4 | $8.32M | Sell |
174,483
-13,054
| -7% | -$603K | 0.02% | 568 |
|
|
2013
Q3 | $8.02M | Sell |
187,537
-120
| -0.1% | -$4.69K | 0.02% | 592 |
|
|
2013
Q2 | $6.77M | Buy |
+187,657
| New | +$7.26M | 0.02% | 639 |
|
Other funds holding HCA
RhumbLine Advisers's HCA Position: Q2 2026 in Review
RhumbLine Advisers reduced its HCA Healthcare (HCA) stake by 4% in Q2 2026, selling an estimated $4.45M and leaving 250,277 shares worth $97.6M. The position accounts for 0.07% of the portfolio, ranked #225.
RhumbLine Advisers first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $132M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- RhumbLine Advisers held 250,277 shares of HCA Healthcare worth $97.6M as of Q2 2026.
- RhumbLine Advisers sold 10,534 HCA Healthcare shares in Q2 2026, an estimated $4.45M.
- HCA Healthcare made up 0.07% of RhumbLine Advisers's portfolio in Q2 2026, its #225 holding.
- RhumbLine Advisers first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's HCA Healthcare position peaked at $132M in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.